[1]
“The Current Role of Glycoprotein IIb/IIIa Inhibitors in Percutaneous Coronary Intervention”, Rhythmos, vol. 11, no. 2, pp. 39–48, Apr. 2016, Accessed: Jan. 21, 2026. [Online]. Available: https://www.rhythmos.gr/index.php/Rhythmos/article/view/180